WallStreetZenWallStreetZen

NASDAQ: BIOR
Biora Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BIOR

Based on 1 analyst offering 12 month price targets for Biora Therapeutics Inc.
Min Forecast
$15.00+2,207.69%
Avg Forecast
$15.00+2,207.69%
Max Forecast
$15.00+2,207.69%

Should I buy or sell BIOR stock?

Based on 1 analyst offering ratings for Biora Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BIOR stock forecasts and price targets.

BIOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-13

1 of 1

Forecast return on equity

Is BIOR forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is BIOR forecast to generate an efficient return on assets?
Company
-223.65%
Industry
26.76%
BIOR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BIOR earnings per share forecast

What is BIOR's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.25
Avg 2 year Forecast
-$1.15
Avg 3 year Forecast
-$1.06

BIOR revenue forecast

What is BIOR's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$1.3M+48.84%
Avg 2 year Forecast
$5.0M+481.4%
Avg 3 year Forecast
$5.5M+539.53%
BIOR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BIOR revenue growth forecast

How is BIOR forecast to perform vs Biotechnology companies and vs the US market?
Company
91.98%
Industry
34.96%
Market
9.31%
BIOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BIOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BIOR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BIOR$0.65$15.00+2,207.69%Buy
PTN$1.49$17.00+1,040.94%Buy
BOLT$0.63$3.50+453.80%Hold
UBX$1.44$8.00+455.56%Buy
CGTX$0.61$8.00+1,222.31%Buy
View Top Biotech Stocks

Biora Therapeutics Stock Forecast FAQ

Is Biora Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BIOR) stock is to Buy BIOR stock.

Out of 1 analyst, 0 (0%) are recommending BIOR as a Strong Buy, 1 (100%) are recommending BIOR as a Buy, 0 (0%) are recommending BIOR as a Hold, 0 (0%) are recommending BIOR as a Sell, and 0 (0%) are recommending BIOR as a Strong Sell.

If you're new to stock investing, here's how to buy Biora Therapeutics stock.

What is BIOR's earnings growth forecast for 2024-2026?

(NASDAQ: BIOR) Biora Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.03%.

Biora Therapeutics's earnings in 2024 is -$86,591,000.On average, 2 Wall Street analysts forecast BIOR's earnings for 2024 to be -$45,404,015, with the lowest BIOR earnings forecast at -$60,173,995, and the highest BIOR earnings forecast at -$30,634,034. On average, 2 Wall Street analysts forecast BIOR's earnings for 2025 to be -$41,939,451, with the lowest BIOR earnings forecast at -$49,962,651, and the highest BIOR earnings forecast at -$33,916,252.

In 2026, BIOR is forecast to generate -$38,657,233 in earnings, with the lowest earnings forecast at -$42,668,833 and the highest earnings forecast at -$34,645,634.

What is BIOR's revenue growth forecast for 2024-2026?

(NASDAQ: BIOR) Biora Therapeutics's forecast annual revenue growth rate of 91.98% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Biora Therapeutics's revenue in 2024 is $860,000.On average, 2 Wall Street analysts forecast BIOR's revenue for 2024 to be $46,680,433, with the lowest BIOR revenue forecast at $31,363,416, and the highest BIOR revenue forecast at $61,997,450. On average, 1 Wall Street analysts forecast BIOR's revenue for 2025 to be $182,345,440, with the lowest BIOR revenue forecast at $182,345,440, and the highest BIOR revenue forecast at $182,345,440.

In 2026, BIOR is forecast to generate $200,579,984 in revenue, with the lowest revenue forecast at $200,579,984 and the highest revenue forecast at $200,579,984.

What is BIOR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BIOR) forecast ROA is -223.65%, which is lower than the forecast US Biotechnology industry average of 26.76%.

What is BIOR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BIOR price target, the average BIOR price target is $15.00, with the highest BIOR stock price forecast at $15.00 and the lowest BIOR stock price forecast at $15.00.

The Wall Street analyst predicted that Biora Therapeutics's share price could reach $15.00 by Aug 13, 2025. The average Biora Therapeutics stock price prediction forecasts a potential upside of 2,207.69% from the current BIOR share price of $0.65.

What is BIOR's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: BIOR) Biora Therapeutics's current Earnings Per Share (EPS) is -$4.18. On average, analysts forecast that BIOR's EPS will be -$1.25 for 2024, with the lowest EPS forecast at -$1.65, and the highest EPS forecast at -$0.84. On average, analysts forecast that BIOR's EPS will be -$1.15 for 2025, with the lowest EPS forecast at -$1.37, and the highest EPS forecast at -$0.93. In 2026, BIOR's EPS is forecast to hit -$1.06 (min: -$1.17, max: -$0.95).

What is BIOR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BIOR) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.